The presentation contains no new catalysts or variance from prior disclosures. Monitor next quarterly report for evidence of cost-savings execution and leverage reduction progress.
Price Chart
Executive Summary
Chemours filed an 8-K furnishing its September 2026 investor presentation, which recaps Q2 2026 results, the Pathway to Thrive strategy, and growth initiatives in AI infrastructure and data center cooling. The presentation reiterates known financial data (Net Sales $1,591M, Adj. EBITDA $247M) and forward-looking targets (net leverage below 3x, >$250M cost savings), but does not introduce material new information or guidance changes.
Key Facts
- Q2 2026 Net Sales of $1,591M, down ~1.5% YoY from $1,615M
- Q2 2026 Adj. EBITDA of $247M, down from $260M YoY
- Free Cash Flow improved 128% YoY to $114M; FCF conversion 46%
- Net leverage declined to 4.4x from Q1 2026; targeting below 3x
- Repaid €230M of B-3 Euro-denominated Term Loan in Q2
- Pathway to Thrive targeting >$250M cost reductions by 2027 and >5% sales CAGR from 2024 to 2027
- TT segment targeting mid-cycle Adj. EBITDA floor of $400M without significant volume change
- TSS data center chiller sales expected low-double-digit CAGR into early 2030s
- APM Performance Solutions sales grew 8% YoY, with 40%+ tied to AI infrastructure end markets
- NJ environmental settlement (~$500M NPV) agreed; EPA/WVDEP settlement ($22.5M penalty + $90M mitigation)
Financial Impact
No new financial materiality; Q2 results and forward targets were previously disclosed or aspirational.
Risk Factors
- Legacy PFAS liabilities remain a source of cash outflows and uncertainty
- Execution risk on cost-saving targets and net leverage reduction
- Cyclical demand in TiO2 (Titanium Technologies) could pressure margins
- Regulatory transitions in refrigerants may not materialize as expected
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001627223-26-000027 |
| Document: cc-ex99_1.htm | 0001627223-26-000027 |
| Document: 0001627223-26-000027-index-headers.html | 0001627223-26-000027 |
| Document: 0001627223-26-000027-index.html | 0001627223-26-000027 |
| Document: 0001627223-26-000027.txt | 0001627223-26-000027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 8-K | $15.07 $14.44 | ▼ −4.18% | ▼ −3.68% | $13.74 (−8.79%) |
Sep 9, 2026 23d ago | 8-K | $15.04 $14.73 | ▼ −2.06% | ▼ −1.73% | $13.74 (−8.61%) |
Aug 14, 2026 6w ago | Institutional Cluster | $15.72 $15.39 | ▲ +2.10% | ▲ +0.91% | $13.74 (+12.56%) |
Aug 13, 2026 7w ago | Insider Cluster | $15.26 $15.69 | ▲ +2.82% | ▲ +4.78% | $13.74 (−9.93%) |
Aug 11, 2026 7w ago | Insider Cluster | $14.80 $15.42 | ▲ +4.19% | ▲ +4.59% | $13.74 (−7.13%) |
Aug 4, 2026 8w ago | Press Release | $14.59 $15.24 | ▼ −4.46% | ▼ −4.10% | $13.74 (+5.79%) |
Aug 4, 2026 8w ago | Press Release | $14.59 $15.24 | ▲ +4.46% | ▲ +4.10% | $13.74 (−5.79%) |
Jul 23, 2026 10w ago | Press Release | $17.22 $17.11 | ▼ −0.64% | ▼ −1.01% | $13.74 (−20.18%) |
Jun 3, 2026 17w ago | Court Ruling | $22.61 $20.31 | ▼ −10.17% | ▼ −6.35% | $13.74 (−39.21%) |
May 5, 2026 21w ago | 8-K | $23.67 $24.67 | ▲ +4.22% | ▲ +3.09% | $13.74 (−41.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access